Vasiliki Pantazou

Has grant

Chief Resident in Neurology

Centre Hospitalier Universitaire Vaudois

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Microglial contact with Ranvier Node during myelination

Open Date: 2020-11-01

Close Date: 2021-10-01

Grant: Close

Young Investigator Award - Clinical

Open Date: 2019-11-01

Close Date: 2020-03-01

Grant: Close

Multiphenotypic analysis of ocrelizumab treatment effect on PBMCs

Open Date: 2019-11-01

Close Date: 2020-10-01

Articles (8)

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Raphael Bernard-Valnet

SWITZERLAND

View details

Marie Théaudin

University of Lausanne

SWITZERLAND

View details

Rainer Tan

Head of the medical migrant health unit / Clinical researcher

Centre for Primary Care and Public Health (Unisanté), University of Lausanne

SWITZERLAND

View details

Renaud Du Pasquier

Full professor

University of Lausanne

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vasiliki Pantazou

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (8)

Ocrelizumab Impairs the Phenotype and Function of Memory CD8+T Cells

Recurrence of disease activity after fingolimod discontinuation in older patients previously stable on treatment

Interaction between Neurons and the Oligodendroglial Lineage in Multiple Sclerosis and Its Preclinical Models

Is disease activity prior to fingolimod initiation predictive of response? Fingolimod as a "common" first line treatment.

Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation.

Vaccine-associated measles in a patient treated with natalizumab: a case report.

First-ever treatment in multiple sclerosis.

ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis.

Collaborators (4)

Raphael Bernard-Valnet

Marie Théaudin

Rainer Tan

Renaud Du Pasquier

Make your next move.